Research
Bringing a new cancer drug to market
By Laura Abbott | November 26, 2018
Two decades ago, Poul Sorensen made a discovery that would lead to the development of a cancer drug that shrinks many different kinds of tumours.
UBC researchers find gene signature that predicts outcome after spinal cord injury
By bkladko | October 5, 2018
The authors, including MD/PhD students, integrated data from decades of small-scale studies using a systems biology approach.
Lowering levels of Huntington disease-causing protein restores cognitive function in mice
By bkladko | October 3, 2018
After receiving pieces of DNA called antisense oligonucleotides, the mice also became less anxious and depressed.
Midwifery linked to lower odds of birth complications for low-income women
By bkladko | October 3, 2018
The researchers looked at records for 58,000 British Columbia women, looking for incidence of small-for-gestational age birth, pre-term birth and low birth weight for low-income women.
Child abuse could leave “molecular scars” on its victims
By bkladko | October 1, 2018
The researchers found a distinctive and significant difference in chemical tags on 12 regions of the genome.
Cannabis use could help people stay on treatment for opioid addiction
By bkladko | September 20, 2018
Daily use of cannabis was associated with a 21 per cent higher chance of remaining in opioid agonist treatment programs.
Hardwired for laziness? Tests show the human brain must work hard to avoid sloth
By bkladko | September 18, 2018
Moving avatars toward pictures of physical activity required volunteers’ brains to work harder.
More specialized harm reduction services needed for women who use drugs
By bkladko | September 12, 2018
Some overdose prevention sites are perceived as “masculine” spaces.
HPV vaccine shows higher failure rate in girls or women living with HIV
By bkladko | September 11, 2018
Researchers compared health outcomes of a group of vaccinated Canadian women and girls with HIV with a previously-studied cohort of vaccinated women and girls without HIV.
Rare but recurring mutations discovered in ER-positive breast cancer
By bkladko | September 4, 2018
The uncommon mutations were associated with early relapse and death, and thus stand out as therapeutic targets.